Company Filing History:
10 out of 462 
1 out of 1 Years Active: 1998-2016
Title: Joseph W Harding: Innovator in Otoprotection and Therapeutic Agents
Introduction
Joseph W Harding is a notable inventor based in Pullman, WA (US), recognized for his contributions to the field of otoprotection and therapeutic agents. With a total of 10 patents, Harding has made significant strides in developing innovative methods to combat ototoxicity and other health challenges.
Latest Patents
Among his latest patents is a groundbreaking method titled "Lead compound for otoprotection: targeting HGF signaling with dihexa." This invention presents a novel approach to preventing or reducing ototoxicity in vertebrates undergoing treatment with platinum-based chemotherapeutic agents, such as cisplatin or aminoglycoside antibiotics. The method involves administering an effective amount of an otoprotective agent comprising Dihexa either prior to, concurrently with, or following the administration of the chemotherapeutic agent. Another significant patent is "Hepatocyte growth factor mimics as therapeutic agents," which focuses on small molecule and peptidic mimics of hepatocyte growth factors. These molecules have shown potential therapeutic applications for various conditions, including dementia, neurodegenerative diseases, diabetes, metabolic syndrome, cancer, and defective wound healing.
Career Highlights
Joseph W Harding has had a distinguished career, working with esteemed institutions such as Washington State University and Pacific Northwest Biotechnology Inc. His work has not only advanced scientific understanding but has also paved the way for new therapeutic strategies.
Collaborations
Throughout his career, Harding has collaborated with notable colleagues, including John W Wright and Leen H Kawas. These partnerships have contributed to the development of innovative solutions in the biomedical field.
Conclusion
Joseph W Harding's contributions to the fields of otoprotection and therapeutic agents highlight his role as a leading inventor. His innovative patents and collaborations reflect a commitment to advancing healthcare solutions.